Health Trials

Focal-Onset Seizure

2

Review clinical trials related to Focal-Onset Seizure. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine RAP-219 Long- term safety and open-label antiseizure activity in patients with Refractory Focal Epilepsy.

Participants needed: 30
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Rapport Therapeutics Inc.Updated: Jan 23, 2026Locations: 7
Eligibility criteria

Completion of the associated parent study (RAP-219-FOS-201) treatment period wit... [+6]

Known of hypersensitivity to RAP-219 [+2]

Read more
Status: Recruiting

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients With Focal Onset or Primary Generalized Tonic-Clonic Seizures

Participants needed: 50
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Praxis Precision MedicinesUpdated: Apr 3, 2025Locations: 11
Eligibility criteria

A diagnosis of focal onset seizures or idiopathic generalized tonic clonic seizu... [+3]

History of pseudo or psychogenic seizures, or cluster seizures only, within the... [+10]

Read more